GlobeNewswire by notified

ABN AMRO reports net profit of EUR 343 million in Q3 2021

Share

ABN AMRO reports net profit of EUR 343 million in Q3 2021

  • Net profit EUR 343 million; return on equity 6.5% in Q3 2021, 7.8% excluding CIB non-core
  • Strong fee incomegrowth of 19% excluding non-core, while deposit margin pressure persists
  • Demand for lendingshowed signs of recovery; corporate and mortgage loan books grew
  • Cost of risk for 2021 expectedto be around nil as the credit environment remains benign
  • Strong capital position, Basel III CET1 ratio of 17.8% (Basel IV CET1 of around 16%); constructive dialogue with regulator on potential share buybacks

Robert Swaak, CEO, comments:

Developments in the third quarter were encouraging: Dutch society has largely reopened and government support has been withdrawn, though the rise in Covid infectionsremains a concern. Demand for lending showed signs of recovery and both our mortgage book and corporate loan book grew.Our clients increasingly focus on the future and we are there to support them through our trusted relationships and expertise. We continue to deliveron our agenda as we are well ahead of plan in the wind-down of the CIB non-core portfolio, we have paid out the final 2019 dividend, have agreed a compensation scheme for revolving consumer credit and are simplifying our organisational structure.

Net profit in Q3 2021 was EUR 343 million, delivering a 6.5% return on equity (7.8% excluding CIB non-core) despite continued pressure on net interest income and a EUR 217 million provision for revolving consumer credit. While pressure from deposit margins and the CIB non-core wind-down continues, our operating performance remained solidand fee income improved by 19% (excluding CIB non-core).Impairments showed a small net release of EUR 12 million as the credit environment remained benign. We expect the cost of risk for 2021 to bearound nil.Our capital position remains very strong, with a Basel III CET1 ratio of 17.8% (Basel IV around 16%). We are in a constructive dialogue with the regulator on potential share buybacks after the FY 2021 results have been announced.

We are a personal bank in the digital age, with our strategic pillars – customer experience, sustainability and future-proof bank –as our guiding principles. We bring convenience into the daily lives of our clients and expertise when it matters. Our digital personal assistant, Anna, supports clients in their day-to-day banking.She already handles half of all chat requests, making our service more efficient and personal while enabling our advisers to focus on expertise. We encourage our clients to make their homes more sustainable and have now extended our sustainability discount to include homes with energy label B. I am very pleased that our ESG client assets (in line with Sustainable Finance Disclosure Regulation definitions and disclosures) have grown to EUR 39 billion. We are building a future-proof bank, digital by design, and continue to transfer services to our mobile banking app, including cash withdrawals at ATMs.

Key figures and indicators
(in EUR millions)
Q3 2021Q3 2020ChangeQ2 2021Change9M 20219M 2020Change
Operating income 1,734 2,207 -21% 1,732 5,313 6,115 -13%
Operating expenses 1,301 1,357 -4% 1,228 6% 4,372 3,856 13%
Operating result432850-49%504-14%9402,260-58%
Impairment charges on financial instruments -12 270 -79 -85% -168 2,083
Income tax expenses 102 279 -64% 190 -47% 426 275 55%
Profit/(loss) for the period34330114%393-13%682-99
Cost/income ratio 75.1% 61.5% 70.9% 82.3% 63.0%
Return on average Equity1 6.5% 5.6% 7.6% 4.2% -1.3%
Fully-loaded CET1 ratio 17.8% 17.2% 18.3% 17.8% 17.2%
1 Based on profit for the period attributable to the owners of the parent company


ABN AMRO Press Office
Jarco de Swart
pressrelations@nl.abnamro.com
+31 20 6288900
ABN AMRO Investor Relations
Ferdinand Vaandrager
investorrelations@nl.abnamro.com
+31 20 6282282



This press release is published by ABN AMRO Bank N.V. and contains inside information within the meaning of article 7 (1) to (4) of Regulation (EU) No 596/2014 (Market Abuse Regulation)


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Baltic Horizon Fund consolidated audited results for 202329.3.2024 10:35:00 CET | Press release

Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City Life’ strategy, introduced to investors in summer 2023, is paramount to their best interests. In the coming years, we expect two thirds of the Fund’s NOI to come from the centrally located ‘Modern City Life’ multi-fu

Progress on ABN AMRO share buyback programme 22 – 28 March 202429.3.2024 08:00:00 CET | Press release

Progress on ABN AMRO share buyback programme 22 – 28 March 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 22 March 2024 up to and including 28 March 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.47 for a total amount of €46,409,760.00. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme. To date the total consideration for shares and depositary receipts repurchased amounts to €279,519,000.00 representing 55.9% of the overall share buyback programme. ABN AMRO Press Office pressrelations@nl.abnamro.com +31 20 6288900ABN AMRO Investor Relations investorrelations@nl.abnamro.com +31 20 6282282 This press release is published by ABN AMRO Ba

Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind29.3.2024 07:00:00 CET | Press release

Press release Brussels, 29 March 2024 Regulated information – Inside information Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind On 20 November 2023, Orange Belgium SA (the “Company”) received notification from Nethys SA (“Nethys”) of its wish to contribute its 25% + 1 shareholding in VOO Holding SA (“VOO”) to the capital of the Company, provided that such contribution results in Nethys holding at least 11% of the Company's share capital (after contribution), pursuant to the provisions of the shareholders' agreement entered into by and between the Company, Atlas Services Belgium SA (“ASB”) and Nethys on 2 June 2023. Nethys can be considered a “related” party to the Company within the meaning of the IAS standards, as it has significant influence over VOO within the meaning of IAS and VOO is part of the group to which the Company belongs. Date and value of the planned t

McWhorter Foundation Combats Nelson Peltz’s Outdated Ideologies and Advocates for Sustainable Inclusivity In Corporate Leadership29.3.2024 06:59:56 CET | Press release

PALM BEACH, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- C.K. McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction. After encountering instances of racism and exclusivity on Town of Palm Beach Island (known as home to Jeffrey Epstein, Nelson Peltz and others), McWhorter reflects on the disconnect between elite boardroom discussions and the realities faced by diverse communities. While briefly meeting Nelson Peltz and shaking hands after both departed separate lunches, McWhorter initially respected his insights. However, recent comments made by Peltz suggesting Disney should avoid inclusive films have raised eyebrows and prompted McWhorter to speak out. "It's concerning when influential figures like Peltz advocate against inclusivity in entertainment," McWhorter comments. "The future is in diversity and representation, especially as millennial a

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates29.3.2024 05:24:27 CET | Press release

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue was approximately RMB1,503 million during 2023. The revenue from pharmaceutical products increased by approximately 58% compared to 2022. The sales revenue of TUOYI® (toripalimab) was approximately RMB919 million, representing an increase of approximately 25% compared to the previous year.Total research and development (“R&D”) expenses were approximately RMB1,937 million in 2023, representing a decrease of approximately 19% compared to 2022. The decrease in R&D expenses was mainly due to the strategic management of R&D investments in certain early-stage pipelines, while optimizing resource all

HiddenA line styled icon from Orion Icon Library.Eye